Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420 [PMID: 30487952 DOI: 10.4251/wjgo.v10.i11.410]
Corresponding Author of This Article
Abdullah Sakin, MD, Doctor, Department of Medical Oncology, Yuzuncu Yil University Medical School, Tuşba/Van 65090, Turkey. drsakin@hotmail.com
Research Domain of This Article
Oncology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Nov 15, 2018; 10(11): 410-420 Published online Nov 15, 2018. doi: 10.4251/wjgo.v10.i11.410
Table 1 Comparison of clinical and pathological data according to tumor localization
All patients
RCC
LCC
(n = 942)
(n = 456)
(n = 486)
n
%
n
%
n
%
P
Age (yr)
< 65
636
67.5
304
66.7
332
68.3
0.590
≥ 65
306
32.5
152
33.3
154
31.7
Gender
Male
511
54.2
250
54.8
261
53.7
0.730
Female
431
45.8
206
45.2
225
46.3
Family history
No
916
97.2
439
96.3
477
98.1
0.790
Yes
26
2.8
17
3.7
9
1.9
Smoking status
No
592
62.8
277
60.7
315
64.8
0.192
Yes
350
37.2
179
39.3
171
35.2
Alcohol use status
No
893
94.8
434
95.2
459
94.4
0.614
Yes
49
5.2
22
4.8
27
5.6
Mode of surgery
Elective
791
84
400
87.7
391
80.5
0.002
Emergent
151
16
56
12.3
95
19.5
DM
No
845
89.7
407
89.3
438
90.1
0.527
Yes
93
9.9
48
10.5
45
9.3
HT
No
717
76.1
344
75.4
373
76.7
0.329
Yes
223
23.7
112
24.6
111
22.8
Histology
Adenocarcinoma
779
82.7
356
78.1
423
87
< 0.001
Mucinous adenocarcinoma
163
17.3
100
21.9
63
13
Tumor grade
Well and moderately
879
93.3
420
92.1
459
94.4
0.151
Poorly
63
6.7
36
7.9
27
5.6
Tumor stage
II
567
60.2
271
59.4
296
60.9
0.644
III
375
39.8
185
40.6
190
39.1
pT stage
T1-2
133
14.1
57
12.5
76
15.6
0.267
T3
752
79.8
374
82
378
77.8
T4
57
6.1
25
5.5
32
6.6
The number of removed lymph nodes
< 12
296
31.4
102
22.4
194
39.9
< 0.001
≥ 12
646
68.6
354
77.6
292
60.1
pN
N0
567
60.2
269
59
298
61.3
0.589
N1
273
29
133
29.2
140
28.8
N2
102
10.8
54
11.8
48
9.9
PNI
Negative
728
78.3
354
78.5
374
78.1
0.879
Positive
202
21.7
97
21.5
105
21.9
LVI
Negative
629
67.8
303
67.3
326
68.2
0.777
Positive
299
32.2
147
32.7
152
31.8
Surgical margin
Negative
928
98.5
449
98.5
479
98.6
0.096
Positive
8
0.8
6
1.3
2
0.4
Adjuvant treatment
No
208
22.1
94
20.6
114
23.5
0.293
Yes
734
77.9
362
79.4
372
76.5
Adjuvant treatment regimen
5-FU-based
493
67.2
243
67.1
250
67.2
0.978
Oxaliplatin-based
241
32.8
119
32.9
122
32.8
Completion rate of adjuvant treatment
695
94.7
344
95
351
94.4
0.685
Tumor recurrence
No
804
85.4
389
85.3
415
85.4
0.971
Yes
138
14.6
67
14.7
71
14.6
Locoregional recurrence
40
29
21
31.3
19
26.8
0.553
Systemic recurrence
98
71
46
68.7
52
73.2
Metastasectomy
48
34.8
24
35.8
24
33.8
0.804
Status
Exitus
95
9.1
51
11.2
44
9.1
0.278
Alive
847
90.9
405
88.8
486
90.9
Median
Min-Max
Median
Min-Max
Median
Min-Max
Age (yr)
58
19-94
57
19-89
58
21-94
0.141
Follow-up (mo)
90
1-252
90
1-252
90
5-235
mean
SD
mean
SD
mean
SD
Number of removed lymph nodes
17.57
10.843
19.78
11.059
15.5
10.223
< 0.001
Number of metastatic lymph nodes
1.46
4.068
1.41
2.86
1.5
4.944
0.743
Table 2 Disease free survival and overall survival rates (%) at 12, 36, 60, 90, 120 and 180 mo according to tumor localization
All patients (%)
RCC (%)
LCC (%)
DFS (mo)
Stage II
Stage III
Stage II
Stage III
12
97.9
98.9
96.2
98.0
96.8
36
89.8
93.9
83.6
94.5
81.9
60
87.0
93.1
79.4
91.8
78.2
90
84.9
92.6
75.9
91.3
76.7
120
84.4
92.0
75.0
90.5
74.4
180
82.7
90.3
73.2
90.5
72.2
OS (mo)
12
99.8
99.3
100.0
99.7
100.0
36
96.7
96.2
95.5
99.3
94.4
60
92.4
94.5
86.2
97.0
87.9
90
89.5
94.0
82.5
94.4
86.4
120
87.6
92.7
78.9
93.8
82.9
180
86.6
92.7
78.9
92.1
82.9
Table 3 Factors affecting disease free survival
Univariate analysis
Multivariate analysis
HR
95%CI
P
HR
95%CI
P
Age (yr)
< 65
1
1
≥ 65
1.779
1.268
2.496
0.001
1.88
1.305
2.708
0.001
Gender
Male
1
Female
0.96
0.686
1.343
0.812
Family history
No
1
Yes
1.195
0.489
2.919
0.696
Smoking status
No
1
Yes
0.908
0.641
1.287
0.587
Alcohol using status
No
1
Yes
0.372
0.118
1.167
0.09
Mode of surgery
Elective
1
1
Emergent
1.796
1.22
2.646
0.003
1.718
1.131
2.611
0.011
DM
No
1
Yes
0.973
0.549
1.724
0.925
HT
No
1
Yes
1.541
0.967
2.224
0.067
Histology
Adenocarcinoma
1
Mucinous adenocarcinoma
1.207
0.793
1.839
0.38
Tumor grade
Well and moderately
1
Poorly
1.574
0.889
2.787
0.119
Tumor location
RCC
1
LCC
0.997
0.714
1.392
0.984
Tumor stage
II
1
1
III
2.99
2.109
4.238
< 0.001
2.281
1.485
3.505
< 0.001
pT stage
T1 + 2
1
< 0.001
T2
1.912
0.999
3.662
0.05
T4
9.308
4.478
19.348
< 0.001
Number of removed lymph nodes
≥ 12
1
1
< 12
2.166
1.421
3.301
< 0.001
1.751
1.13
2.712
0.012
pN
N0
1
< 0.001
N1
2.779
1.908
4.047
< 0.001
N2
3.56
2.237
5.664
< 0.001
PNI
Negative
1
1
Positive
3.953
2.801
5.578
< 0.001
2.277
1.549
3.347
< 0.001
LVI
Negative
1
1
Positive
3.372
2.382
4.774
< 0.001
1.825
1.221
2.728
0.003
Surgical margin
Negative
1
Positive
3.884
1.436
10.505
0.008
Adjuvant treatment
No
1
1
Yes
0.591
0.346
0.954
0.041
0.514
0.323
0.82
0.005
Table 4 Factors affecting overall survival
Univariate analysis
Multivariate analysis
HR
95%CI
P
HR
95%CI
P
Age (yr)
< 65
1
1
≥ 65
4.136
2.731
6.263
< 0.001
4.049
2.578
6.358
< 0.001
Gender
Male
1
Female
0.951
0.636
1.423
0.808
Family history
No
1
Yes
0.306
0.043
2.196
0.239
Smoking status
No
1
Yes
0.815
0.533
1.247
0.346
Alcohol using status
No
1
Yes
0.348
0.086
1.411
0.139
Mode of surgery
Elective
1
Emergent
1.342
0.812
2.219
0.252
DM
No
1
Yes
1.683
0.953
2.972
0.073
HT
No
1
Yes
3.067
2.035
4.623
< 0.001
Histology
Adenocarcinoma
1
Mucinous adenocarcinoma
1.213
0.733
2.006
0.452
Tumor grade
Well and moderately
1
Poorly
1.036
0.453
2.369
0.933
Tumor location
RCC
1
LCC
0.807
0.539
1.208
0.297
Tumor stage
II
1
1
III
2.363
1.57
3.557
< 0.001
1.723
1.037
2.863
0.036
pT stage
T1 + 2
1
< 0.001
T2
4.836
1.526
15.326
0.007
T4
21.34
6.162
73.897
< 0.001
Number of removed lymph nodes
≥ 12
1
< 12
1.402
0.897
2.192
0.138
pN
N0
1
< 0.001
N1
2.122
1.353
3.327
0.001
N2
3.015
1.742
5.219
< 0.001
PNI
Negative
1
1
Positive
3.653
2.4
5.562
< 0.001
2.198
1.374
3.517
0.001
LVI
Negative
1
1
Positive
3.735
2.445
5.707
< 0.001
2.523
1.543
4.127
< 0.001
Surgical margin
Negative
1
Positive
2.57
0.633
10.435
0.187
Adjuvant treatment
No
1
1
Yes
0.587
0.379
0.91
0.017
0.517
0.311
0.86
0.011
Citation: Sakin A, Arici S, Secmeler S, Can O, Geredeli C, Yasar N, Demir C, Demir OG, Cihan S. Prognostic significance of primary tumor localization in stage II and III colon cancer. World J Gastrointest Oncol 2018; 10(11): 410-420